Benign neoplasm: Lymph nodes

CD2_BENIGN_LYMPHNODES_EXALLC

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data
1. Apply sex-specific rule None	-
2. Check conditions None
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D36.0& Hospital discharge: ICD-9 — 2298A Cause of death: ICD-10 — D36.0& Cause of death: ICD-9 — 2298A 2 out of 7 registries used, show all original rules.	-
4. Check minimum number of events None	-
5. Include endpoints None	-
6. Filter based on genotype QC (FinnGen only) None	-

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D36
Name in latin: Neoplasma benignum lymphonodorum

NAME	CD2_BENIGN_LYMPHNODES_EXALLC
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D360
HD_ICD_9	2298A
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D360
COD_ICD_9	2298A
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign neoplasm: Lymph nodes based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Benign neoplasm: Lymph nodes

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	96	65	31
Unadjusted period prevalence (%)	0.02	0.02	0.01
Median age at first event (years)	47.07	45.60	50.15

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
87: Matched controls
870

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D36.0

ICD-10 Finland

Benign neoplasm: Lymph nodes

+∞

117.2

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

+∞

16.1

EP1AE

NOMESCO Finland

Neck ultrasound examination

20.7

7.8

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

15.9

6.6

PJA10

NOMESCO Finland

Exploration of lymph nodes

75.1

6.5

A04AA02

ATC

granisetron; systemic, transdermal

+∞

6.3

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(4035726)

9.00

9.07

1.7

1.1

—

(40768795) Lymph node Pathology biopsy report

+∞

5.25

1.0

0.0

—

(3001604) Monocytes [#/volume] in Blood

371

2.53

4.63

7.2

4.9

0.6

e9/l

0.15

315

(3013115) Eosinophils [#/volume] in Blood

382

2.52

4.56

7.5

5.2

0.2

e9/l

0.44

334

(3006315) Basophils [#/volume] in Blood

373

2.51

4.55

7.4

4.9

0.0

e9/l

0.61

318

(3019198) Lymphocytes [#/volume] in Blood

381

2.42

4.23

7.2

4.9

1.9

e9/l

0.02

330

(3023368) Bacteria identified in Blood by Culture

152

2.42

3.62

6.5

3.7

—

(40760892) CBC W Ordered Manual Differential panel - Blood

169

2.34

3.51

4.5

4.0

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3.05

3.33

2.1

1.3

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

304

2.07

3.04

4.6

3.5

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2.65

2.92

3.8

2.8

1.0

mmol/l

0.22

(3026008) Bacteria identified in Urine by Culture

225

2.05

2.78

3.3

3.1

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

414

2.01

2.77

10.9

6.0

4.0

4.2

e9/l

0.38

356

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2.34

2.60

2.1

1.6

—

(3019150) Specific gravity of Urine by Refractometry

175

2.04

2.48

5.2

3.7

1.0

kg/l

—

(40768804) Tissue Pathology biopsy report

251

1.93

2.44

2.4

1.6

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

5.25

2.44

1.2

1.3

—

(3052851) Hemolysis interference index of Serum or Plasma

5.25

2.44

1.3

2.3

—

(3018010) Neutrophils/100 leukocytes in Blood

350

1.89

2.43

7.7

4.6

55.5

56.3

0.17

330

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

287

1.90

2.41

3.3

3.4

28.6

46.7

ng/l

0.72

177

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

4.35

2.41

1.3

1.5

—

(3021601) Nitrite [Presence] in Urine by Test strip

390

1.88

2.36

6.9

4.9

0.0

estimate

—

(3035350) Ketones [Presence] in Urine by Test strip

390

1.88

2.36

4.8

3.5

0.0

estimate

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

124

2.12

2.33

2.2

1.6

—

(3041096) Erythrocytes [Presence] in Urine by Automated

222

1.91

2.26

3.3

3.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

3.89

2.19

1.4

1.1

—

(42870588) Differential panel, method unspecified - Blood

243

1.85

2.13

7.6

4.6

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

2.20

2.12

2.3

1.4

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

4.19

2.07

1.2

2.5

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2.55

2.04

2.5

1.4

—

(40760888) Immunoglobulin light chains.free panel - Serum

4.73

1.96

2.0

1.0

—

(3002256) Pathology report gross observation

2.39

1.94

1.4

1.1

—

(4010399)

2.39

1.94

2.1

1.4

—

(3009261) Glucose [Presence] in Urine by Test strip

397

1.75

1.92

4.9

3.5

0.0

estimate

—

(3037467) Urinalysis macro (dipstick) panel - Urine

528

1.80

1.88

6.2

4.0

—

(3012544) pH of Venous blood

2.35

1.87

2.1

2.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2.35

1.87

5.0

3.6

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2.22

1.87

2.2

1.6

—

(3037756) Immunofixation for Serum or Plasma

4.33

1.84

2.2

1.0

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2.15

1.76

2.3

1.6

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

3.71

1.63

1.6

2.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

2.71

1.54

2.0

1.7

—

(1761482) Bacteria [#/volume] in Urine by Culture

2.98

1.53

3.0

3.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

322

1.61

1.44

7.8

3.6

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1.91

1.39

4.0

2.0

0.8

mmol/l

1.99

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

3.04

1.37

1.4

2.1

232.2

200.2

—

(3044290) Cell count panel - Cerebral spinal fluid

3.04

1.37

1.0

1.2

—

(3015736) pH of Urine

308

1.58

1.34

5.0

3.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

159

1.68

1.28

2.4

2.0

—

(3018418) pH of Serum or Plasma

212

1.60

1.25

8.3

2.6

7.4

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

2.72

1.23

1.2

2.1

97.6

91.8

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2.20

1.21

2.0

1.8

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

136

1.70

1.21

1.6

1.9

709.8

450.2

pmol/l

0.79

116

(3037522) Nuclear Ab [Titer] in Serum

112

1.75

1.19

2.1

1.5

250.0

905.7

titre

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

343

1.52

1.19

9.8

4.0

1.2

mmol/l

0.22

299

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2.01

1.17

2.0

1.9

0.2

g/l

1.08

(3024561) Albumin [Mass/volume] in Serum or Plasma

298

1.52

1.15

6.1

3.3

35.1

36.1

g/l

0.50

283

(3003327) Ova and parasites identified in Stool by Light microscopy

2.44

1.15

1.1

1.4

—

(3029937) Albumin [Presence] in Urine by Test strip

208

1.56

1.13

4.9

3.7

0.0

estimate

—

(3020891) Body temperature

2.45

1.10

3.2

3.7

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

158

1.60

1.07

1.6

1.3

10.8

28.5

iu/ml

—

(3013707) Erythrocyte sedimentation rate by Westergren method

590

1.52

1.05

6.2

3.8

14.0

10.4

mm/h

0.78

550

(3044889) 12 lead EKG panel

528

1.49

1.05

3.5

3.4

—

(3019060) Gas panel - Arterial blood

2.08

1.02

4.3

4.1

—

(40761535) Cells panel - Urine sediment

1.88

1.00

3.6

3.4

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

259

1.48

1.00

3.5

2.9

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

152

1.58

1.00

1.6

1.3

10.8

u/ml

—

(3025941) Bacteria identified in Stool by Culture

1.84

0.98

1.1

1.3

—

(3018095) Leukocytes [#/volume] in Urine

279

1.46

0.97

4.1

3.5

30.5

78.5

e6/l

0.99

193

(3015377) Calcium [Moles/volume] in Serum or Plasma

226

1.48

0.92

2.1

1.8

2.4

2.3

mmol/l

0.76

197

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

156

1.53

0.89

2.0

1.6

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

192

1.49

0.88

1.4

1.3

0.9

1.7

u/ml

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1.85

0.87

1.3

1.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

149

1.52

0.85

1.3

1.5

—

(3000991) Gas panel - Venous blood

1.81

0.85

2.4

4.3

—

(3044640) Blood type and Crossmatch panel - Blood

212

1.45

0.83

3.1

1.8

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

187

1.46

0.79

5.8

3.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

0.00

0.78

0.0

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.63

0.76

2.0

1.9

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1.86

0.74

2.7

4.2

25.8

25.3

mmol/l

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1.86

0.74

1.9

2.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

2.05

0.74

1.4

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

2.05

0.74

1.4

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

2.05

0.74

1.4

1.2

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1.57

0.71

2.1

1.9

2.4

2.3

g/l

0.08

(3000330) Specific gravity of Urine by Test strip

1.68

0.68

4.9

3.0

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1.64

0.66

1.6

—

(3009542) Hematocrit [Volume Fraction] of Blood

730

0.73

0.66

24.2

11.7

38.7

40.7

1.10

557

(3022621) pH of Urine by Test strip

1.62

0.62

3.6

2.5

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1.62

0.62

1.9

1.5

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1.70

0.62

1.0

2.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

151

1.41

0.60

3.7

3.3

116.8

130.1

ng/l

0.06

106

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

0.54

0.59

1.4

1.8

—

(3008898) HLA-B27 [Presence]

1.71

0.58

1.0

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

110

1.43

0.52

2.2

2.1

—

(3032080) INR in Blood by Coagulation assay

276

1.30

0.52

13.2

8.2

1.4

1.2

inr

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.44

0.49

2.3

2.0

—

(3007853) Bacteria identified in Skin by Aerobe culture

1.45

0.47

1.4

1.7

—

(1761868) Lipid panel - Serum or Plasma

311

0.78

0.47

3.2

2.7

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.43

0.46

1.3

1.8

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

131

1.36

0.46

1.5

1.9

2.5

2.4

mmol/l

0.90

110

(3021589) Normoblasts [#/volume] in Blood

339

1.25

0.45

18.0

7.1

0.0

e9/l

0.00

269

(3013139) Helicobacter pylori Ag [Presence] in Stool

1.39

0.42

1.1

1.2

—

(3042936) Bacteria identified in Isolate by Culture

1.39

0.42

2.9

1.7

—

(40761511) CBC panel - Blood by Automated count

836

0.74

0.42

23.3

10.4

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1.54

0.42

2.2

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1.54

0.42

1.6

1.5

—

(3028300) Cannabinoids [Presence] in Urine

1.50

0.41

1.0

1.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1.50

0.41

2.0

1.6

—

(3027008) Opiates [Presence] in Urine

1.50

0.41

1.0

1.4

—

(3027944) Amphetamines [Presence] in Urine

1.45

0.40

1.0

1.4

—

(3000764) Benzodiazepines [Presence] in Urine

1.45

0.40

1.0

1.4

—

(40761536) Microorganisms panel - Urine sediment

1.40

0.40

3.6

3.1

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1.42

0.36

2.5

3.4

6.0

9.2

mmol/l

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1.39

0.35

2.7

1.8

8.2

15.4

nmol/l

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1.32

0.33

2.3

1.1

—

(36304419) Bacteria [Presence] in Urine

205

1.23

0.31

3.3

2.7

—

(40768797) Stomach Pathology biopsy report

120

0.72

0.29

1.1

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.27

0.28

2.8

1.9

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

304

1.18

0.28

2.2

1.9

91.2

98.2

pmol/l

0.44

137

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.30

0.28

3.3

1.9

—

(3020682) Albumin/Creatinine [Ratio] in Urine

220

0.83

0.25

4.4

3.9

8.3

8.0

mg/mmol

0.01

145

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

107

1.25

0.23

1.2

1.7

1.9

1.5

0.44

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

0.00

0.21

0.0

1.4

—

7.7

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

0.21

0.0

1.8

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

551

0.88

0.21

4.3

3.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.00

0.21

0.0

1.1

—

(3045424) Erythrocytes [Presence] in Urine

0.00

0.21

0.0

1.3

—

(3019225) pH of Specimen

1.22

0.18

2.9

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

0.73

0.17

1.4

1.5

—

(3000492) Spirometry study

1.14

0.16

1.0

1.3

—

(3013512) EKG study

208

0.89

0.12

4.9

3.4

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

794

1.13

0.10

24.3

10.7

22.4

20.6

mg/l

0.23

594

(40758558) Short blood count panel - Blood

186

0.90

0.10

10.5

4.8

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1.09

0.10

1.2

1.1

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1.08

0.09

3.5

2.5

124.8

76.2

ng/l

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1.05

0.08

1.9

2.6

5.7

6.1

ug/l

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

0.87

0.07

1.4

1.5

—

(3022145) Colonoscopy Study observation

1.12

0.05

2.0

1.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

159

1.08

0.05

1.8

1.4

—

(3000494) Fungus identified in Specimen by Culture

1.11

0.04

3.5

1.3

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

827

0.94

0.01

26.1

12.3

71.7

73.4

umol/l

0.43

827

(3009508) Creatinine [Moles/volume] in Urine

227

0.96

0.01

2.8

3.0

7.1

7.7

mmol/l

0.25

191

(3012516) Albumin [Mass/volume] in Urine

203

0.98

0.00

3.3

3.2

3030.5

49.1

mg/l

0.49

132

(3003694) ABO and Rh group [Type] in Blood

206

1.02

0.00

2.1

1.4

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

734

0.98

0.00

22.3

9.8

84.1

82.7

ml/min/173m2

0.21

579

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

0.00

0.0

2.2

—

16.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

0.00

0.0

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(21494755) Public health laboratory ask at order entry panel

1.01

0.00

1.4

1.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

0.0

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

0.0

1.6

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

0.00

0.0

1.8

—

(4146454)

0.00

0.0

4.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

0.00

0.0

1.0

—

(3000093) Morphology [Interpretation] in Blood Narrative

0.00

0.0

1.0

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

0.00

0.0

1.0

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

0.00

0.0

1.0

—

(3006270) Folate [Moles/volume] in Blood

0.00

0.0

1.4

—

430.2

—

(3014271) Vancomycin [Susceptibility]

0.00

0.0

2.4

—

(36660697) Celiac disease serology panel - Serum

0.94

0.00

1.1

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.8

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.2

—

(3015183) Erythrocyte sedimentation rate

0.00

0.0

1.0

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

0.00

0.0

1.4

—

1.7

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

0.0

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

0.90

0.00

9.0

7.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

0.00

0.0

2.7

—

413.8

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

0.0

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

0.0

1.1

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

0.00

0.0

2.0

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

0.00

0.0

1.3

—

43.5

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.00

0.0

1.6

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

0.0

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

0.00

0.0

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.00

0.0

1.1

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

0.00

0.0

1.2

—

6.4

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_LYMPHNODES_EXALLC – Benign neoplasm: Lymph nodes

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Benign neoplasm: Lymph nodes

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints